Nash Huw M.
SEC CIK 1780085 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | Chief Business Off | 33 | — | $2.65M | 21 | 2021-07-01 | 2024-07-02 |
Most active insiders at STOK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Krainer Adrian R. | Dir | — | $3.90M |
| 2 | Kaye Edward M. MD | Dir | — | $3.18M |
| 3 | Ticho Barry | Chief MEDICAL Off | — | $1.98M |
| 4 | Allan Jonathan | GC, CORP SEC | — | $1.56M |
| 5 | TZIANABOS ARTHUR | Interim Executive COB, Dir | — | $174.2K |
| 6 | Leggett Thomas | CFO | — | $147.1K |
| 7 | Hoitt Jason | Chief Patient Off | — | $119.3K |
| 8 | LEVIN ARTHUR A | Dir | — | $22.3K |
Nash Huw M. made no open-market trades at STOK in the last 12 months.
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-07-03 | 2024-07-02 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | Chief Business Off | S - Sale | $13.11 | -2,500 | 33 | -99% | -$32.8K |
| D | 2024-05-22 | 2024-05-20 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | S - Sale+OE | $15.39 | -50.0K | 0 | -100% | -$769.5K |
| D | 2024-05-22 | 2024-05-20 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | M - OptEx | $0.4 | +50.0K | 50.0K | New | +$20.0K |
| DM | 2024-04-03 | 2024-04-01 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | S - Sale+OE | $13.22 | -61.3K | 400 | -99% | -$810.9K |
| D | 2024-04-03 | 2024-04-01 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | M - OptEx | $0.4 | +50.0K | 61.3K | +441% | +$20.0K |
| D | 2024-03-19 | 2024-03-15 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | M - OptEx | $0.00 | +13.1K | 15.4K | +559% | $0 |
| D | 2024-03-19 | 2024-03-19 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | S - Sale+OE | $6.10 | -4,116 | 11.3K | -27% | -$25.1K |
| DM | 2022-01-05 | 2022-01-03 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | S - Sale+OE | $23.07 | -3,800 | 0 | -100% | -$87.7K |
| D | 2022-01-05 | 2022-01-03 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | M - OptEx | $2.19 | +3,800 | 3,800 | New | +$8,322 |
| DM | 2021-12-03 | 2021-12-01 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | S - Sale+OE | $24.44 | -5,700 | 2,500 | -70% | -$139.3K |
| D | 2021-12-03 | 2021-12-01 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | M - OptEx | $2.19 | +5,700 | 5,700 | New | +$12.5K |
| DM | 2021-11-03 | 2021-11-01+ | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | S - Sale+OE | $24.03 | -5,700 | 1,610 | -78% | -$137.0K |
| DM | 2021-11-03 | 2021-11-01+ | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | M - OptEx | $2.19 | +5,700 | 3,800 | New | +$12.5K |
| D | 2021-10-04 | 2021-10-01 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | S - Sale+OE | $24.83 | -5,700 | 0 | -100% | -$141.5K |
| D | 2021-10-04 | 2021-10-01 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | M - OptEx | $2.19 | +5,700 | 5,700 | New | +$12.5K |
| D | 2021-09-02 | 2021-09-01 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | M - OptEx | $2.19 | +5,700 | 5,700 | New | +$12.5K |
| D | 2021-09-02 | 2021-09-01 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | S - Sale+OE | $26.00 | -5,700 | 0 | -100% | -$148.2K |
| D | 2021-08-04 | 2021-08-02 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | S - Sale+OE | $28.87 | -5,700 | 0 | -100% | -$164.6K |
| D | 2021-08-04 | 2021-08-02 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | M - OptEx | $2.19 | +5,700 | 5,700 | New | +$12.5K |
| D | 2021-07-02 | 2021-07-01 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | S - Sale+OE | $33.33 | -5,700 | 0 | -100% | -$190.0K |
| D | 2021-07-02 | 2021-07-01 | STOK | Stoke Therapeutics, Inc. | Nash Huw M. | COO, CBO | M - OptEx | $2.19 | +5,700 | 5,700 | New | +$12.5K |
Purchase Sale Sale after option exercise All abbreviations